Emergent Biosolutions (EBS) has a market capitalization of $467.5M, based on 51.6M shares at a price of $9.06 (up 3.9% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
May 2026 | $8.54 | 2,246,495 | 51,596,294 | $440,632,350.76 |
April 2026 | $8.23 | 12,966,500 | 51,596,294 | $424,637,499.62 |
March 2026 | $8.30 | 22,296,266 | 56,500,000 | $468,950,000.00 |
February 2026 | $8.15 | 17,043,037 | 56,500,000 | $460,475,000.00 |
January 2026 | $11.34 | 19,251,712 | 56,500,000 | $640,710,000.00 |
December 2025 | $12.36 | 17,789,602 | 52,400,000 | $647,664,000.00 |
November 2025 | $11.17 | 19,649,932 | 52,400,000 | $585,308,000.00 |
October 2025 | $12.48 | 28,597,900 | 52,400,000 | $653,952,000.00 |
September 2025 | $8.82 | 21,010,300 | 56,500,000 | $498,330,000.00 |
August 2025 | $8.30 | 29,595,402 | 56,500,000 | $468,950,000.00 |
July 2025 | $5.88 | 23,895,400 | 56,500,000 | $332,220,000.00 |
June 2025 | $6.38 | 26,942,408 | 54,200,000 | $345,796,000.00 |
May 2025 | $6.32 | 29,795,300 | 54,200,000 | $342,544,000.00 |
April 2025 | $5.34 | 23,274,356 | 54,200,000 | $289,428,000.00 |
March 2025 | $4.86 | 31,233,989 | 57,300,000 | $278,478,000.00 |
February 2025 | $7.48 | 20,766,468 | 57,300,000 | $428,604,000.00 |
January 2025 | $11.25 | 19,751,101 | 57,300,000 | $644,625,000.00 |
December 2024 | $9.56 | 22,652,561 | 54,200,000 | $518,152,000.00 |
November 2024 | $10.12 | 32,384,276 | 54,200,000 | $548,504,000.00 |
October 2024 | $9.06 | 29,910,505 | 54,200,000 | $491,052,000.00 |
September 2024 | $8.35 | 45,413,791 | 55,600,000 | $464,260,000.00 |
August 2024 | $8.31 | 94,849,658 | 55,600,000 | $462,036,000.00 |
July 2024 | $12.71 | 60,689,045 | 55,600,000 | $706,676,000.00 |
June 2024 | $6.82 | 48,214,806 | 52,600,000 | $358,732,000.00 |
May 2024 | $5.70 | 234,848,386 | 52,600,000 | $299,820,000.00 |